NYLI Candriam U.S. Mid Cap Equity ETFIQSM
Type
ETF
Peer group
US equity: mid companies
Net assets
$315.0M
Expense ratio
0.15%
1-year return
+19.7%
3 years, a year
+13.4%
5 years, a year
—
12-month yield
1.06%
Holdings
243
What it aims to do.
The NYLI Candriam U.S. Mid Cap Equity ETF (the Fund) seeks investment results that correspond (before fees and expenses) generally to the price and yield performance of its underlying index, the NYLI Candriam U.S. Mid Cap Equity Index (the Underlying Index).
Top 10 holdings.
| Holding | % of fund |
|---|---|
| JOBY Technipfmc Plc | 1.31% |
| JOBY Fabrinet | 1.13% |
| RVMD Revolution Medicines Inc | 1.10% |
| XPO Xpo Inc | 1.09% |
| MTZ Mastec Inc | 1.09% |
| UTHR United Therapeutics Corp | 1.05% |
| JOBY Nvent Electric Plc | 0.99% |
| ALB Albemarle Corp | 0.99% |
| TWLO Twilio Inc | 0.88% |
| CHRW Ch Robinson Worldwide Inc | 0.87% |
More on IQSM.
- IQSM overview
- IQSM holdings
- IQSM risk
- IQSM costs
- IQSM money in and out
- IQSM share classes
- Compare IQSM with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.